Mounjaro: What Type of Drug Is It for Weight Loss? (2025 Update) - Mustaf Medical

Mounjaro: What Type of Drug Is It for Weight Loss? (2025 Update)

Are you struggling with weight loss, especially if you also have type 2 diabetes? You've likely heard of Mounjaro. But what is Mounjaro, exactly? This comprehensive guide will break down everything you need to know about this increasingly popular medication, including its mechanism, efficacy, potential side effects, and whether it's the right choice for you. We'll cover the latest updates for 2025, ensuring you have the most current information available.

What Type of Drug Is Mounjaro?

Mounjaro is the brand name for tirzepatide, a relatively new injectable medication approved by the FDA. But what type of drug is Mounjaro specifically? It falls into a class of medications called glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptor agonists. This mouthful means it mimics hormones naturally produced in your gut to regulate blood sugar and appetite.

Unlike some medications that target just GLP-1, tirzepatide acts on both GLP-1 and GIP receptors. This dual action makes it particularly effective, often resulting in more significant weight loss and better blood sugar control compared to GLP-1 agonists alone.

Key Takeaway: Mounjaro is a dual GLP-1/GIP receptor agonist, meaning it works on two different hormone receptors to regulate blood sugar and appetite.

How Does Mounjaro Work?

To truly understand Mounjaro, let's dive a bit deeper into the science. The dual action of tirzepatide (Mounjaro) works in several ways:

  • Increases Insulin Release: When blood sugar rises after eating, tirzepatide stimulates the pancreas to release more insulin, helping glucose to be absorbed by cells for energy.
  • Suppresses Glucagon: Glucagon is a hormone that raises blood sugar. Mounjaro reduces its production, preventing blood sugar from spiking.
  • Slows Gastric Emptying: This means food stays in your stomach longer, making you feel fuller for longer, and reducing overall food intake.
  • Reduces Appetite: Mounjaro affects the brain, reducing cravings and the drive to eat. in fact, studies show a notable impact on reward centres in the brain, reducing food desire.

The combination of these effects leads to both improved blood sugar control and weight loss.

Mounjaro for Weight Loss: What Does the Research Say?

Mounjaro wasn't originally developed specifically for weight loss, but its ability to promote weight loss quickly became apparent in clinical trials for type 2 diabetes. Subsequent dedicated trials have confirmed its efficacy for weight loss.

  • SURPASS-2 Trial: A key trial showed that participants taking tirzepatide lost an average of up to 22.5% of their body weight over 72 weeks (around 1.5 years).
  • SURMOUNT-1 Trial: This trial demonstrated that Mounjaro, when used alone, led to significant weight loss.
  • SURMOUNT-2 Trial: This trial focused on patients with obesity but without diabetes and showed comparable weight loss results.

Compared to other weight loss medications or lifestyle interventions alone, Mounjaro often produces more significant and sustained weight loss. However, it's important to remember that individual results will vary.

Who Is Mounjaro For? Approved Uses & Considerations

Currently, Mounjaro is FDA-approved for two main uses:

  1. Type 's type 2 Diabetes: To improve blood sugar control in adults with type 2 diabetes.
  2. Obesity or Overweight with At Least One Weight-Related Condition: The FDA expanded approval in 2022 to include weight management for adults with obesity or overweight and at least one weight-related condition like high blood pressure, high cholesterol, or type 2 diabetes.

Who should not use Mounjaro?

  • People with a history of pancreatitis: Mounjaro can increase the risk of pancreatitis.
  • People with medullary thyroid carcinoma (a type of thyroid cancer): Mounjaro may increase the risk.
  • People with Multiple Endocrine Neoplasia syndrome type a (MENA):
  • Women who are pregnant or planning to become pregnant.

Mounjaro Dosage & Administration

Mounjaro is an injectable medication, administered once weekly. The dosage varies depending on individual needs and goals.

  • Initial Dose: Typically, the starting dose is 2.5 mg once weekly for 4 weeks.
  • Titration: Your doctor will likely increase the dose every 4 weeks until the maximum dose of 15mg is reached.
  • Administration: Mounjaro is injected under the skin. Your doctor or a healthcare professional will show you how to give the injection properly.
  • Individualized approach: The dosage will be tailored to the patients.

Mounjaro Side Effects

Like all medications, Mounjaro can cause side effects. Here are some of the most common:

  • Gastrointestinal Issues: Nausea, vomiting, diarrhoea, constipation, bloating. These are generally mild to moderate and tend to subside over time.
  • Injection site reaction:
  • Fatigue:
  • Headache:
  • Hypoglycemia: (Low blood sugar) particularly when combined with other diabetes medications.
  • Gallbladder problems: Can occur, though less common.
  • Pancreatitis: (Inflammation of the pancreas) a less common, but more serious side effect.

Serious side effects: Require immediate medical attention.

Mounjaro vs. Other Weight Loss Medications

Several other weight loss medications are available. Here's a comparison:

Medication Type Average Weight Loss Main Side Effects
Mounjaro (Tirzepatide) GLP-1/GIP agonist Up to 22.5% Gastrointestinal issues, nausea
Ozempic (Semaglutide) GLP-1 agonist Up to 15% Gastrointestinal issues, nausea
Wegovy (Semaglutide) GLP-1 agonist Up to 15% Gastrointestinal issues, nausea
Qsymia (Phentermine/Topiramate) Appetite suppressant Up to 10% Insomnia, constipation, dry mouth
Contrave (Naltrexone/Bupropion) Combination Up to 5% Nausea, headache, constipation
what type of drug is mounjaro

Source: Mayoclinic

Mounjaro often has a slight edge when it comes to both weight loss and glycemic control, compared to the first generation GLP-1 agonists.

Long-Term Use and Maintenance

Once a patient reaches their weight loss goal with Mounjaro, the question arises: do they need to stay on the medication forever?

The answer isn' to stay on the medication for a long time to avoid regaining the weight.

Cost and Insurance Coverage

Mounjaro can be expensive, and insurance coverage can vary.

  • List price: around $995 per month
  • Insurance: The price is determined by your insurance policy, so its important to speak with your provider.

Mounjaro Availability in 2025: Potential Supply Issues

In 2023-2024, Mounjaro has experienced supply challenges and intermittent shortages. While Eli Lilly is working to increase production, it's important to be aware of potential shortages in 2025 and plan accordingly.

How to Best Utilize Mounjaro: Lifestyle Factors

Mounjaro is a powerful tool, but it's most effective when combined with a healthy lifestyle.

  • Diet: A low calorie diet, rich in nutrients.
  • Exercise: Aim for at least 150 minutes of moderate-intensity exercise per week.
  • Hydration: Drink plenty of water.
  • Sleep: Get 7-8 hours of sleep per night.
  • Stress Management: Employ techniques like meditation or yoga.

Mounjaro: A Long-term Solution for Weight Management?

Mounjaro is a groundbreaking medication with the potential to help many people struggling with weight loss and type diabetes. It's important to remember that Mounjaro is not a magic bullet. It works best when combined with a commitment to a healthy lifestyle.

FAQ

1. What type of drug is Mounjaro and how does it work for weight loss?
Mounjaro (tirzepatide) is a dual GLP-1/GIP receptor agonist. It mimics hormones that regulate blood sugar and appetite, leading to increased insulin release, suppressed glucagon, slowed gastric emptying, and reduced appetite.

2. What are the common side effects of Mounjaro?
Common side effects include nausea, vomiting, diarrhea, constipation, bloating, and fatigue.

3. Is Mounjaro safe for everyone?
No. Mounjaro is not recommended for individuals with a history of pancreatitis, medullary thyroid carcinoma, or Multiple Endocrine Neoplasia syndrome type A.

4. Will I regain weight if I stop taking Mounjaro?
The answer to the question is yes, weight regain is common if you stop taking Mounjaro without maintaining a healthy lifestyle.

5. What is the difference between Mounjaro and Ozempic?
Both are GLP-1 agonists, but Mounjaro also activates GIP receptors, leading to higher weight loss and improved blood sugar control.

Disclaimer:
This content is for informational purposes only. Always consult with a healthcare professional before starting any supplement or treatment.